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Abstract
The Collaborative Cross (CC) is an emerging panel of recombinant inbred mouse strains. Each 
strain is genetically distinct but all descended from the same eight inbred founders. In 66 strains 
from incipient lines of the CC (pre-CC), as well as the 8 CC founders and some of their F1 
offspring, we examined subsets of lymphocytes and antigen-presenting cells. We found significant 
variation among the founders, with even greater diversity in the pre-CC. Genome-wide association 
using inferred haplotypes detected highly significant loci controlling B-to-T cell ratio, CD8 T-cell 
numbers, CD11c and CD23 expression. Comparison of overall strain effects in the CC founders 
with strain effects at QTL in the pre-CC revealed sharp contrasts in the genetic architecture of two 
traits with significant loci: variation in CD23 can be explained largely by additive genetics at one 
locus, whereas variation in B-to-T ratio has a more complex etiology. For CD23, we found a 
strong QTL whose confidence interval contained the CD23 structural gene Fcer2a. Our data on 
the pre-CC demonstrate the utility of the CC for studying immunophenotypes and the value of 
integrating founder, CC, and F1 data. The extreme immunophenotypes observed could have 
pleiotropic effects in other CC experiments.
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Understanding the genetics of the immune system has been critical in unraveling the 
mechanisms of the major questions in immunology of the past 50 years including antibody 
diversity, T cell recognition and the function of the major histocompatibility complex. Many 
of the major causes of immunodeficiency caused by single gene mutations have been 
identified and their mechanism elucidated 1.Many of the major causes of immunodeficiency 
caused by single gene mutations have been identified and their mechanism elucidated1. Now 
interest has shifted towards understanding interacting genes, and with it, complex genetics 
where a large number of common variants individually or through interactions each exert 
small but interacting effects on the lymphoid and myeloid development. Examples here 
include immune- mediated diseases such as asthma and type 1 diabetes 2, 3.
The mouse has been critical to progress in understanding the molecular basis of single gene 
diseases, and offers considerable promise for understanding diseases with more complex 
genetic architectures (e.g., 4 and refs therein). Here we report on the use of a new mouse 
genetic resource, the Collaborative Cross, as a way to probe the immune system function. 
The Collaborative Cross (CC) is an eight-way recombinant inbred (RI) panel conceived as a 
next-generation platform and community resource for systems genetics 5. The eight founders 
of the CC consist of five ‘classical’ laboratory strains (short names in parentheses): 129S1/
SvImJ (129S1), A/J (AJ), C57BL/6J (B6), NOD/ShiLtJ (NOD), NZO/HlLtJ (NZO); and 
three ‘wild-derived’ strains CAST/EiJ (CAST), PWK/PhJ (PWK), WSB/EiJ (WSB). The 
resulting CC lines, each bred from a structured and randomized combination of these eight 
founders, surpass any available RI panel in genetic diversity, number of recombination 
events (and hence potential QTL mapping resolution), and eventually in number of available 
strains 6-9. From an experimental design perspective, the CC offers greater reproducibility 
and balance than outbred populations of similar genetic diversity. Specifically, because each 
CC strain is inbred, experiments on it can be replicated, and because pairs of CC strains are 
genetically different from each other by an approximately even degree, examining the 
effects of polymorphisms across a group of strains is (at its best) akin to a randomized and 
balanced assignment of alternative genetic treatments and their combinations. Production of 
the CC population was initiated in 2005 10-12 Three different cohorts of CC mice are in 
existence5, and our analysis focuses only on strains initiated at The Oak Ridge National 
Laboratory (ORNL). Analysis of incipient CC strains (pre-CC) from ORNL demonstrated 
balanced allele frequencies and well-distributed recombination events 13. Inbreeding of the 
CC lines is ongoing with up-to-date information on the status and availability of lines at 
http://www.csbio.unc.edu/CCstatus/ 14. Our report complements several recent studies 
examining different phenotypes in the pre-CC. 5, 13, 15, 16.
In our initial phenotyping of the pre-CC mice we chose to focus on the differences among 
well defined leukocyte subsets that could be effectively defined using flow cytometry. In all 
immune phenotypes measured, we found variation in the pre-CC strains exceeding that 
found in the founder strains. We also found striking outliers in some traits suggesting 
immune dysregulation in some of the pre-CC strains. Despite residual heterozygosity and 
the use of a very small cohort of pre-CC strains, we identified several QTLs, one of which 
(CD23 surface expression) we were able to localize to plausible coding mutations in a single 
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gene of known function. The present genetic analyses add to a growing body of evidence 
supporting the potential power of the CC for the study of a variety of phenotypes. Our 
observations of extreme outlier immunological phenotypes in the pre-CC mice also have 
implications for other phenotyping studies performed on the pre-CC mice and completed CC 
strains.
Results
Founder strains have diverse resting immune phenotypes
In order to assess the contribution of each of the founder strains to the immunological 
diversity of the pre-CC lines, we analyzed mice from all eight CC founder strains (121 
inbred mice) and from 31 of their F1 crosses (132 F1 hybrid mice). Splenocytes from all 
strains were analyzed using a nine-parameter flow cytometric panel consisting of antibodies 
staining subsets of T-cells, B-cells, and antigen-presenting cells (APCs). We established a 
single, thorough data analysis scheme for our flow cytometry data which was applied to 
every sample analyzed (description in Table 1, example gating scheme in Supplemental 
Figure 1.1). Our analysis scheme defined a total of 21 different phenotypes derived from our 
flow data (Table 1). Every batch of samples analyzed included a B6 male spleen to help with 
standardization. We used mean fluorescent intensity (MFI) to measure the level of protein 
expression on the cell surface, calibrating this measurement against a subset (61/70) of B6 
mice used as controls. For this reason, although as many as 70 B6 mice are included in our 
analyses of non-MFI phenotypes, the 61 used as controls are necessarily excluded from 
phenotype data (see CD11c MFI, CD11b MFI and CD23 MFI in Table 1). We found that 19 
of 21 of our measured immunophenotypes showed highly significant differences among the 
founder strains (see Table 1).
In this communication we summarize the immune phenotypes, and focus on three 
illustrative points (while including results on all phenotypes in Supplemental Material). 
First, the observed phenotypes are complex with 15 independently measured principal 
components required to capture all of the phenotypic variation. Second, we identified QTL 
that contribute to immunologically important variation, especially T/B ratios, and the 
genetics of these are complex. Further a strong QTL for CD23 expression maps on 
chromosome 8 at or near Fcer2, the gene that encodes CD23. Finally examination of the 
parental strains that show large variations of CD23 expression show that these do not control 
the level of circulating IgE as had been suggested by Ford and co-workers 17.
Diversity in the pre-CC strains is greater than observed in the founders
We analyzed 66 pre-CC strains, that is, incipient CC strains that had undergone sister-
brother mating for at least five generations. In many immunophenotypes analyzed, the pre-
CC showed greater variability than that observed in the founders. In some cases, we found 
extreme phenotypes representing profound disruption in lymphocyte homeostasis (Figure 1). 
For example, several pre-CC strains had a notable T-cell lymphopenia, with H57+ cells 
constituting a mere 5-10% of the total splenocytes (Figure 1a). We also identified pre-CC 
strains with extremely high CD4/CD8 ratios (∼9 CD4/ 1 CD8), and interestingly, inverted 
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CD4/CD8 ratios (Figure 1b). Such apparent immune dysregulation was not identified in the 
founders or any of the F1 hybrids analyzed.
Figure 2 plots trait correlations among the 66 pre-CC, 121 inbred and 132 F1 mice and 
indicates that some traits were highly correlated, notably those defining T cell subsets. The 
percentage of B cells and the percentage of T cells, unsurprisingly, correlates strongly with 
the B/T cell ratio. Surprisingly, however, the number of independent traits was quite high: a 
principal components analysis showed that 15 uncorrelated composite traits would be 
required to explain 99% of the variation provided by the 21 measured phenotypes. This 
suggests substantial independent control of these traits (Figure 3), and is consistent with 
many immune traits depending on multiple interaction genetic pathways rather than a few 
highly influential loci.
QTL identified for lymphocyte subsets
When we performed a genome-wide scan in the pre-CC for genetic loci associated with 
changes in B/T ratio, we found two strong peaks on chromosome 6 centered at 23Mb and 
91Mb (Figure 4; Table 2). T cell receptor beta (61Mb), Ig kappa genes (70 Mb) as well as 
NK receptor (129 Mb) genes map on mouse chromosome 6. In addition to significant 
associations noted for B/T ratios, MFI of CD23, % of T cells, % of B cells, % of CD8 cells, 
MFI CD11c and % of transitional B cells (see Figure S1 for scans of phenotypes without 
genome-wide significant QTL). The genome of each pre-CC strain is a distinct mosaic of the 
haplotypes from the original eight founders, and so at any given QTL the impact of genetic 
variation in the region can be described in terms of strain effects; that is, estimated 
substitution effects of the eight founder haplotypes. The strain effects at the 23Mb QTL peak 
for B/T ratio on chromosome 6 (Figure 5) include a strong positive effect on B/T ratio by the 
PWK strain haplotype and a strong negative effect by CAST. An independent pattern of 
strain effects is seen at the second chrosome 6 peak for B/T (at 91Mb), which includes a 
strong positive effect of the NZO haplotype. It is tempting to speculate on the role of WASL 
that maps in 24664995 on chromosome 6, and lies just outside the 1.5 LOD drop interval 
(but well within the more conservative bootstrap interval; Table 2). The protein is a member 
of the Wiskott-Aldrich syndrome family and may play a role in cyto-skeletal rearrangement 
during signaling. Wiskott-Aldrich syndrome protein (WASP) itself is important in T and B 
cell differentiation 18, 19. In the more distal region another effect is mediated by NZO 
encoded alleles. Although this segment is very large, it does contain skap55 that regulates 
binding to LFA1 in response to CCR7 20 as well as Nod1, all important in innate immunity, 
clearly multiple epistatic genes located in cis on the NZO background could be critical.
Low levels of CD23 are detected among the founders
Three of the CC founder strains, 129S1, CAST, and PWK had a consistently low-CD23 
phenotype. Interestingly, in contrast to previous observations in the NZB and 129X1, we 
found that only two of the three CC founders with low-CD23 had relatively high serum-IgE 
(Figure 6c). To characterize further the overall genetic architecture of CD23 surface 
expression, we analyzed our available F1 data jointly with the founder data as an incomplete 
diallel.21. This showed that inheritance of CD23 MFI could be largely explained by an 
additive model of strain effects, wherein 129S1, CAST, and PWK contribute strong negative 
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effects and WSB contributes a strong positive effect on the phenotype (Supplementary 
Figures 9.8 and 9.9). To confirm the observations made in our analysis of the diallel, we 
specifically analyzed CD23 MFI of F1 crosses of 129S1, CAST, and PWK with the B6. In 
agreement with the additive effects observed in the incomplete diallel, we found that F1 
hybrids from crosses of the low-CD23 strains with B6 have a CD23 MFI which is 
significantly higher than the low-CD23 strains (Bonferroni's Post-Test p < 0.05) and 
significantly lower than the B6, suggesting that the alleles responsible for low-CD23 in 
129S1, CAST, and PWK are semidominant in their effect.
Low levels of CD23 in pre-CC map to a QTL on chromosome 8
The ‘low-CD23’ phenotype was also observed in the pre-CC. This may be due to an allele 
common to the 129S1, CAST, and PWK founders: during analysis of the founders and the 
pre-CC, we found a surprising phenotype in B cells whereby CD23 surface expression 
appeared extremely reduced if not completely absent as measured by MFI (Figure 6a). 
CD23 is classically used together with CD21 to discriminate subsets of CD19 positive B-
cells: Follicular B-cells (CD23hi, CD21mid), Marginal Zone B-cells (CD21hi, CD23lo) and 
Transitional B-cells (CD23lo, CD21lo). CD23 (Fcer2a) is the low affinity receptor for IgE. 
A low-CD23 phenotype has been described in the 129X1/SvJ and the NZB/BlN inbred 
strains which was associated with Hyper-IgE and enhanced parasite clearance17, 22. We 
determined that three of the CC founder strains, 129, CAST, and PWK have a low-CD23 
phenotype (Figure 6b). Interestingly, in contrast to previous observations in the NZB and 
129X1, we found that only 2 of the 3 CC founders with low-CD23 had relatively high 
serum-IgE (Figure 6c).
Previous studies of the low-CD23 phenotype in the NZB22 and 129X1 17 suggested that the 
phenotype was produced by a dominant negative mutation in CD23 (Fcer2a) in those 
strains. To understand better the genetic architecture of CD23 surface expression, we 
analyzed our available F1 data (Figure 6 d) jointly with the founder data as an incomplete 
diallel 21. We found that inheritance of CD23 MFI conformed well to an additive model of 
strain effects, wherein 129S1, CAST, and PWK had strong negative effects in the diallel. 
We found no evidence of heterosis, gender effects, or parent of origin effects (not shown) on 
the CD23 phenotype. Mapping indicated that the alleles responsible for low-CD23 in 129S1, 
CAST, and PWK are antimorphic and incompletely dominant.
Given that a low surface CD23 trait had been described in two other strains and associated 
with the coding region of CD23 itself (Fcer2a), we hypothesized the chromosomal region 
surrounding Fcer2a be significant in a linkage map17, 22. Indeed, mapping of CD23 MFI 
yielded a highly significant peak on the centromeric end of chromosome 8, the 1.5 LOD 
drop and bootstrap confidence intervals of which included Fcer2a (Figure 6e). Although 
there are many other genes (271-435, Table 2) in the major CD23 QTL, the afformentioned 
studies and the fact that Fcer2a codes for CD23 both made Fcer2a a strong candidate for 
further analysis. We estimated haplotype effects at all intervals across the chromosome, 
showing that 129S1, CAST, and PWK alleles in the region of Fcer2a appear to reduce 
CD23 MFI, consistent with observations made in the incomplete diallel (Figure 6f). Lastly, 
we visualized the inferred pattern of haplotypes at Fcer2a, which demonstrated an obvious 
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pattern wherein 129S1, CAST and PWK alleles are present in mice with lower CD23 MFI 
and completely absent in mice with the highest CD23 MFI.
Coding mutations in Fcer2a potentially associated with low surface CD23: given the 
haplotype effects at the QTL and the strain effects in the incomplete diallel, we searched for 
mutations within the region Fcer2a in the 129S1, CAST, and PWK strains that might be 
associated with the low-CD23 phenotype using genomic sequence data for the founder 
strains of the CC from (http://www.sanger.ac.uk/cgi-bin/modelorgs/mousegenomes/
snps.pl) 23. We searched for single nucleotide polymorphisms (SNPs) and insertions/
deletions present in the region Fcer2a in the 129S1, CAST, and/or PWK strains. This initial 
screen yielded five plausible SNPs inducing non-synonymous coding mutations in Fcer2a 
(Table 3). Four of the polymorphisms identified had been identified in the 129X1/SvJ15 and 
were all present in the closely related 129/SvImJ. We were able to exclude one 
polymorphism found in the 129X1/SvJ (K131E in the stalk region of CD23)15 since that 
mutation was also found to be present in the WSB/EiJ and the NZO/HlLtJ. We also found 
polymorphisms in the 3′ un-translated region of Fcer2a which were common to all three 
low-CD23 strains as well as the 129X1, but it has already been shown that Fcer2a mRNA 
expression in the 129X1 is not altered.17.
To help narrow further the list of plausible candidates within Fcer2a, we used three 
approaches: merge analysis 24, conditional association, and residue conservation25, 26. Our 
merge score (Table 3; see Methods for calculation) compares the ability of each Fcer2a 
coding polymorphism to explain CD23 MFI variation to the ability of the 8-haplotype 
mosaic in the region of Fcer2a to do the same. It gives a positive value when the coding 
polymorphism explains the association more succinctly than the haplotype mosaic, and a 
negative value when it explains less. It shows that, for example, whereas G117E and K131E 
explain much less than the haplotype mosaic, V87A and S258L explain more.
Conditional association tests to what extent the Fcer2a coding polymorphism can explain 
the association signal at the QTL peak at 15Mb, and in doing so helps to clarify the 
relationship between the CD23 MFI associations at Fcer2a and the QTL peak by testing 
whether they are independent or correlated. Specifically, the conditional LogP measures the 
strength of association at the QTL peak after controlling for a potential effect of the Fcer2a 
polymorphism. In Table 3 this shows that controlling for any of A82T, V87A, S258L and 
D301N drastically reduces the significance of the observed QTL. Although this is consistent 
with there being two separate QTL whose association signals are correlated in the tested set 
of 66 pre-CC lines, the small sample size of this experiment precludes a more thorough 
exploration of this hypothesis.
Discussion
The CC has been proposed as a powerful new tool for system genetics 5. As such, it is 
intended to provide a basis for experiments that aim to study traits under complex genetic 
control in ways that will generalize across, or highlight difference among, multiple genetic 
backgrounds. The CC is also the basis for the Diversity Outbred (DO) population27, a 
randomly mated population similar to heterogeneous stocks (e.g., 28), that shares its initial 
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ancestry with the CC but then through extended outbreeding provides a non-replicable high 
resolution mapping resource that complements the replicable medium-resolution CC panel. 
Thus, phenotypes showing useful variation in the pre-CC are likely also to show useful 
variation in the DO.
The present study shows that the genetic diversity of the CC mice leads to phenotypic 
diversity in the immune system that is not only of potential value for future experiments, 
e.g., for the identification of reliably dysregulated mice, but also in itself for identifying 
genetic variants modulating immune function. Notably, the phenotypic diversity we have 
observed in the pre-CC includes not only that driven by genetic polymorphisms of known 
(or expected) effect, but also that driven by novel or as yet detected genetic variants.
We successfully mapped several immunophenotypic traits in the pre-CC using very few 
mice, a testament not only to the genetic and phenotypic diversity of the pre-CC panel, but 
also the randomized and balanced way in which alternative genetic combinations appear in 
that population. Nonetheless, these pre-CC experiments were subject to several limitations 
which will be remedied in future experiments using the completed CC strains. Principally, 
we were not able to take advantage of the reproducibility of Recombinant Inbred Lines 
(RIL), one of the key strengths of the CC. Residual heterozygosity in the pre-CC strains 
meant that it was not possible to obtain genetically identical mice from any one incipient 
strain 13. More importantly, the number of mice available for the pre-CC experiments was 
relatively small 13. Each strain was available for immunophenotyping only once, and 
significant coordination was required between disparate research groups to distribute tissues 
appropriately. In future experiments with the completed CC, analysis of multiple genetically 
identical mice would increase detection power by increasing apparent heritability of 
measured traits 29. Indeed, successful mapping of susceptibility to Aspergillus fumigatus 
infection has been done using replicates from 66 incipient CC lines from the Wellcome 
Trust Cohort 13, 30. Increased availability of mice will also permit selecting an appropriate 
number of strains for analysis and reanalyzing strains when sample processing errors occur. 
Thus, experiments using the completed CC will have greater detection power and will 
undoubtedly uncover more significant loci.
The QTL mapping of the MFI of CD23 is of interest. Previously it was suggested that CD23 
expression levels regulated circulating IgE, and so was a major regulator of the IgE 
responses.17 The previous data suggested that a coding difference between 129 and BALB/c 
was the major cause of the difference, although a formal genetic analysis was not performed. 
Here we find a major QTL located over the structural gene Fcer2. Further work will be 
required to determine if the QTL we observed is mediated by the Fcer2 gene, another locus 
or an interaction.
We were unable to map some known loci for immunophenotypic traits we analyzed, 
particularly CD4/CD8 ratios. For example, several linkage studies of CD4/CD8 ratios in the 
mouse have pointed to significant regions on chromosome 17 28, 31. Several of those studies 
were done on lymphocyte populations in peripheral blood, and the correlation of CD4/CD8 
ratios between spleen and blood is poor (secondary analysis of primary data available from 
phenome.jax.org, plots not shown here). However, work with reciprocal congenic strains 
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with the B6 and NOD derived MHC (B6-H2g7 and NOD-H2b) has shown that high CD4 
numbers in the lymph nodes were caused by a locus on Chr 17 outside of the MHC 32. 
Future mapping studies in the completed CC and in its complementary resources such as the 
DO are highly likely to map many additional loci not observed in the present study.
Methods
Mice
We collected phenotypes on three sets of mice: those belonging to founder lines of the CC 
(CC founders), F1 crosses of the CC founders, and the incipient Collaborative Cross (pre-
CC).
The CC founder inbred lines are (short names in parentheses): 129S1/SvImJ (129S1), A/J 
(AJ), C57BL/6J (B6), NOD/ShiLtJ (NOD), NZO/HlLtJ (NZO), CAST/EiJ (CAST), 
PWK/PhJ (PWK), and WSB/EiJ (WSB). We obtained mice belonging to these lines from 
the Jackson Laboratory. In total, 112 founder mice were used for phenotyping, with these 
distributed among the strains as (number of mice in parentheses): AJ (6), B6 (70), 129 (6), 
NOD (5), NZO (5), CAST (2), PWK (9), and WSB (9). Of the 70 B6 mice, 61 were 
designated as controls for batch. A further 133 mice were generated from 31 distinct F1 
crosses of (additional and unphenotyped) CC founders, and these F1s were also phenotyped. 
Founders and F1s used for analysis were bred and maintained in house at UNC-Chapel Hill.
The Collaborative Cross is a recombinant inbred (RI) panel derived from the CC founders. 
Each RI line arises from a distinct breeding funnel originating from a distinct 8-way cross of 
the original founder lines. Initiation of the CC breeding funnels, description of the CC 
strains, and animal housing are described elsewhere 10, 11, 13 The CC lines used in this study 
were initiated at The Oak Ridge National Laboratory (ORNL) and transferred to UNC-
Chapel Hill at 9-13 weeks of age. The present work uses mice drawn from the incipient CC 
lines (pre-CC) at UNC, that is, mice from the CC breeding funnels before those funnels have 
reached the 20 generations required for standard inbreeding. We obtained spleens for one 
mouse from each of 66 pre-CC independent lines. As described in 13, the maturity of those 
lines ranged from generation G2:F5 (i.e., 4 generations of inbreeding after initial mixing) to 
G2:F12 (11 generations of inbreeding). All experiments were approved by the Institutional 
Animal Care and Use Committee (IACUC) at UNC-Chapel Hill.
Cell Preparation and Flow Cytometry
Founder strains, F1 offspring and selected pre-CC strains were euthanized and spleens were 
taken for analysis. One B6 mouse, obtained from The Jackson Laboratory, was incorporated 
into every group of samples as a control. Briefly, spleens were ground into suspension in 
cold R10 (RPMI supplemented with 10% v/v fetal bovine serum). Splenocytes were then 
pelleted and resuspended by flicking. One to two milliliters of cold ACK buffer (buffer) 
were added to the cell suspension for 45-60 seconds to lyse erythrocytes. Following lysis, 
ACK buffer was diluted with R10 to approximately 10 mL. Cells were repelleted, 
resuspended in R10 and counted with a hemocytometer. Finally, cells were pelleted once 
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more and resuspended in FC blocking solution (2.4G2 hybridoma supernatant with 0.1% 
azide) prior to aliquoting into appropriate staining solutions.
Splenocytes were stained with a 9-color panel consisting of CD23 (clone B3B4), CD25 
(clone PC-61.5), CD11c (clone N418), CD8 (clone 63-6.7) PerCP, CD19 (clone 6D5), 
CD21 (clone 7E9), CD4 (clone GK1.5), CD11b (clone M1/70), and TCR-Beta (clone 
H57-597). The standard panel with the fluorophores used is shown in Supplemental Table 1. 
Antibodies were used at appropriate dilutions as determined by titration and all appropriate 
single color and fluorophore-minus-one (FMO) controls were included with the samples. 
Cells were stained in FACS wash (PBS supplemented with 2% v/v fetal bovine serum and 
0.1% sodium azide) and cells were fixed with 2% formaldehyde in PBS following the 
staining procedure. Samples were run on a Dako CyAn using the standard 9-color 
instrument configuration and data were collected using Summit 4.3 (Dako). Data were 
analyzed using FlowJo 7.6 (TreeStar) and numerical data were exported to spreadsheets for 
analysis.
Quantitation of Serum IgE. We measured serum IgE of the eight founder strains using a 
pretitrated kit (Biolegend). Pooled serum was obtained from Jackson Laboratories (Bar 
Harbor, Maine). Sera were pooled from two 8-12 week old male mice from each of the eight 
founder strains and 129X1/SvJ as a control. Samples were frozen and shipped on dry ice 
prior to analysis.
Statistical analysis of trait variation in the CC founders and F1 hybrids
To assess the extent to which phenotypes varied among mice from the CC founders we used 
a linear mixed model, testing for the effect of strain on the phenotype while controlling for 
the effect of sex and batch. Prior to analysis, phenotype values were transformed to 
approximate residual normality in order to match the assumptions of the statistical models 
used (Table 1). To maintain interpretability of effects, we achieved this by transforming 
proportions (eg, CD4+) to their logit, ie, to log[y/(1-y)]; applying base 10 logarithms (log10) 
to ratio quantities, which would otherwise be highly left-skewed; and using the Bliss-
corrected inverse normal transformation (INT) for quantities whose distributions were 
otherwise problematic (eg, long-tailed but unsuitable for logit). Strain and sex were modeled 
as fixed effects, while batch was modeled as a random effect. Sex was uncertain for 88 mice, 
including the 61 B6 used as controls (although incomplete records strongly suggested these 
were male); for such mice we set the sex covariate to an intermediate value. The pre-CC 
mice were all male. Significance testing for the effect of strain was performed using a partial 
F-test. To estimate the significance of differences between specific strains, we used the 
Tukey-Kramer test 33. Mixed modeling of strain effects was performed in 34 using the 
packages nlme 35 and multcomp 36. Recognizing that the F1 hybrid data when considered 
jointly with the CC founder data corresponds to an incomplete diallel 37, we estimated 
effects of genetic additivity, heterosis and parent of origin on each phenotype using the R 
package BayesDiallel 21, where batch effects were included as above.
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Genotyping of the pre-CC mice and the SNP arrays used are described thoroughly 
elsewhere. 13, 38 The mice used in this study were described in the preivous reports. 13, 38 In 
short, pre-CC mice were genotyped using test arrays developed as an intermediate step 
toward the development of the Mouse Diversity Array.38 A total of roughly 180,000 SNP 
assays in each array performed well and targeted loci which were polymorphic among the 
founder strains. The number of available SNP markers greatly exceeded the number of 
recombination events 13 allowing accurate inference of founder haplotypes. Genotyping data 
for many pre-CC strains are available for public access at the CC status website (http://
csbio.unc.edu/CCstatus/index.py).
Haplotype reconstruction
Haplotype descent was inferred using HAPPY 39,, which implements a hidden Markov 
model (HMM) that calculates for each individual at each locus along the genome the relative 
proportion of genetic material in that region descended from any given pair of founder 
strains. Specifically, define locus m as the genomic interval between marker m and m + 1, 
and define pi,m(s,t) as the proportion of that interval in mouse i containing the s and t 
haplotypes, such that if pi,m(s,t)=1 and s=t the region is entirely homozygous for strain s. 
HAPPY computes at locus m for each mouse i, the 36 proportions: pi,m(AJ,AJ), pi,m(AJ,B6), 
…, pi,m(WSB,WSB). Because these proportions are calculated as averaged probabilities 
over the interval, we hereafter refer to them as “HAPPY probabilities”. Similar to ref 13 we 
mitigate the effects of undetected genotyping error on the reliability of the haplotype 
reconstruction, we used modified haplotype priors that allowed a conservative genotyping 
error rate of 0.01.
QTL mapping
We performed genome wide linkage disequilibrium (LD) mapping of QTL in the pre-CC by 
testing association at each location along the genome and calculated the statistical 
association between the inferred assignment of founder haplotypes and the phenotype of 
interest. We did this using BAGPIPE (http://valdarlab.unc.edu/software/bagpipe)40, as has 
been used in a number of other pre-CC studies.13, 15, 16 BAGPIPE performs an ANOVA-
like test for how well the haplotypes at each locus explain the variation in phenotype. 
Moreover, to moderate the potentially disruptive effect of residual heterozygosity on 
additive association testing in such a small sample, we used observation weighting based on 
homozygote probabilities. These are described below.
The HAPPY probabilities described earlier (see Haplotype Reconstruction) are used to 
construct two derived quantities for mouse i at locus m. First, the “haplotype dosage” is the 
estimated number of haplotypes ai,m(s) for each haplotype s, calculated as 
. Second, the “homozygote probability” is the probability 
hi,m that the locus is fully inbred, calculated as . We then model the effect 
of a putative QTL at locus m on the transformed phenotype yi collected in batch b for mouse 
i in a linear model:
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where  is the QTL effect, with βAJ,…, βWSB being the eight haplotype 
effects (or “additive strain effects”) that contribute to the effect of that QTL, c is a constant 
intercept term. Bb is the batch effect modeled as a standard random effect for non-MFI 
phenotypes (as in, eg, ref 41 but as a “plug-in” random effect for MFI phenotypes (see 
below), and εi is a mouse-specific noise term. The mouse specific noise is modeled as εi ∼ 
N(0,σ2/hi,m), that is, as having come from a normal distribution with variance scaled 
according to homozygosity. This has a filtering effect, acting to down-weight observations 
from mice to the extent that are considered heterozygous at the locus, and improves our 
power to detect additive-only genetic effects in the pre-CC. The regression in Eq 1 was 
fitted to each locus in the genome in turn, and in each case its goodness of fit was compared 
using a likelihood ratio test with a fit to a null model, namely Eq 1 with the QTL effect 
removed (ie, setting Qi,m = 0).
Batch effects were modeled differently for MFI and non-MFI phenotypes. In non-MFI 
phenotypes, batch effects are minimized by construction: these phenotypes are based on 
relative assessments of intensity through a gating procedure. In MFI phenotypes, day-to-day 
calibration --- in our case, using B6 control mice --- is required, such that the batch effect 
defines the day-specific baseline for the phenotype. In order to obtain stable baseline 
estimates for MFI when often only one B6 control was measured per batch, we used a mixed 
model procedure. Specifically, we first fit a linear mixed model to the log MFI of all mice 
phenotyped (founders, F1s, pre-CCs and B6 controls) with fixed effects of sex and random 
effects for batch and strain. This allowed us to obtained very stable shrinkage estimates, 
known in agricultural statistics as BLUPs 42, for the effect Bb of each batch b using data 
from ∼400 animals. Those Bb estimates, now informed not only by pre-CC mice from the 
same batch but also the B6 controls, were then substituted as fixed “plug-in” values into Eq 
1, and mapping proceeded as above.
Genome-wide significance thresholds were determined by parametric bootstrap for non-MFI 
phenotypes (as in REF 41, 43) and by permutation for MFI phenotypes (as in 13). Confidence 
intervals for QTL location were estimated using the 1.5 LOD-drop method 44 and the more 
conservative positional bootstrap procedure (e.g. 45, 46).
Estimation of strain effects at QTL
Our mapping procedure tests the association between the phenotype under study and the 
inheritance pattern of haplotypes at the QTL. The genetic architecture at a given QTL is 
therefore most appropriately described in terms of its haplotype effects, i.e., the relative 
substitution effect of each founder strain's genetic material at that locus. To estimate 
haplotype effects at identified QTL, we used a mixed model similar to the Bayesian multiple 
imputation procedure in 30 , but incorporating additional parameters that allowed for 
residual heterozygosity and batch effects as described above.
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Merge analysis at coding polymorphisms
Although mapping using an 8-haplotype model of association is powerful for detecting 
QTL, it is most plausible that the number of functional alleles giving rise to a detected signal 
is fewer than eight, with several strain haplotypes possessing the same allele. We used 
merge analysis 24 to measure the statistical support for a coding polymorphism affecting a 
phenotype in a genomic region whose haplotypes already show a strong association. Merge 
analysis helps narrow down the list of potential causal alleles by asking how well the 
observed haplotype association can be explained by a more parsimonious grouping of those 
haplotypes, specifically a grouping that corresponds to a particular coding SNP.
Our merge analysis proceeds as follows. Consider a coding SNP w with alleles v and V 
occurring within the locus m (ie, between genotyped marker m and m+1), and suppose this 
SNP has been genotyped in the 8 CC founder strains but not in the 66 pre-CC mice. Define 
allele count G(s,w) to equal 2 if strain s is known to have only V's at SNP w, 0 if strain s is 
known to have only v's, and 1 if it is a heterozygote. The estimated “allele dosage” at SNP w 
for mouse i can be calculated from the HAPPY probabilities, as . 
If SNP w was entirely responsible for the QTL effect at locus m, then we should be able to 
restate Eq 1 in terms of only the alleles at that SNP. That is, we could replace the 8 
haplotype dosages, ai,m(AJ), …, ai,m(WSB) with the single allele dosage gi,m(w), so that 
Qi,m = βwgi,m(w), and this latter “merged” model should provide as good an explanation of 
how the data arose but with fewer parameters. Using this principle, to evaluate the 
candidacy of a SNP w within its locus m we compare the goodness of fit of the merged 
model at w with that of the haplotype model at m. Goodness of fit in our case was judged 
using the Bayes Information Criterion (BIC) 47, which offsets the deviance of the model (ie, 
its lack of fit) by its parsimony (how few parameters were needed). For each SNP w, this 
leads to a “merge score” ΔBIC(w,m) = BIC(m)-BIC(v,m). Positive values of this merge 
score indicate statistical support for the coding polymorphism; specifically, that the SNP at 
w more concisely explains the QTL effect on the phenotype than does the haplotype-based 
model at that locus.
Sequence Analysis
Analyses for specific polymorphisms in selected regions were done using gene information 
in MGI and publicly available genome sequences of the CC founder strains available from 
the Sanger Mouse Genomes Project (http://www.sanger.ac.uk/resources/mouse/genomes). In 
particular we made extensive use of the SNP/Indel viewer available for the Sanger Mouse 
Genomes Project (http://www.sanger.ac.uk/cgi-bin/modelorgs/mousegenomes/snps.pl).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Immunophenotypic diversity in the CC founders and pre-CC strains. Strain means are shown 
embedded within the entire pre-CC dataset. Founder strains are indicated using the standard 
colors. Males and females are pooled. Error bars represent standard of deviation, except for 
CAST/EiJ where error bars represent range. A) T-cells (H57+) as a fraction of all cells in the 
spleen. Values are untransformed with values ranging from 0.043 (4.3%) to 0.72 (72%). B) 
Ratio of CD4+ to CD8+ T-cells. Data are transformed using the natural log in order to 
normalize the distribution and expose outliers. The untransformed ratios range from 0.50 to 
8.65 CD4+ per CD8+ T-cell.
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Correlations among 21 immunophenotypes among 121 inbred, 133 F1 and 66 pre-CC mice. 
Each block represents the correlation between two (transformed) phenotypes, with the top-
left to bottom-right diagonal of black blocks depicting correlation of +1. Shading indicates 
strength of correlation; white diagonal lines indicate positive vs negative correlation. 
Correlation is based on between 276 and 319 paired observations, depending on phenotype.
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Principal Components Analysis (PCA) indicates that more than 99% of the variance of the 
21 phenotypes can be explained by 15 statistically independent composite phenotypes (PCs).
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Genome scans of pre-CC mice with significant or near-significant QTL. The x-axis plots 
location in the genome, y-axis gives statistical significance of association with the 
phenotype. Dashed horizontal lines indicate genomewide significance at the 0.05, 0.1, and 
0.2 level.
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Founder strain effects at QTL for B/T ratio (log scale). Plot (A) shows the estimated dosage 
effect of each founder strain's haplotype at each locus along chr 6, with identified significant 
or suggestive QTL indicated by dashed vertical lines. Plot (B) gives Bayesian confidence 
intervals for effects within the QTL identified between 23.397-24.369Mb.
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CD23 Mean Fluorescence Intensity in the Founder Strains and F1 crosses. A) B-cell subsets 
as defined by CD21 and CD23 in the B6 (gray) and PWK (red). Note that there is very little 
difference in CD21 expression between the two strains, while CD23 in the PWK is 
extremely reduced if not absent. B) CD23 surface expression in the founder strains. All MFI 
measurements are normalized to the B6 control in each experiment. Males and females are 
pooled. Note low CD23 levels in 129S1, CAST, and PWK. C) ELISA for serum IgE. Pooled 
sera were obtained from 8-12 week old males from each of the founder strains. Pooled 
serum from the 129X1 was also included as a positive control for high IgE. Error bars reflect 
assay precision. D) Inheritance of CD23 MFI in F1 crosses of the B6 with 129S1, CAST, 
and PWK. Reciprocal crosses, males and females are all pooled. E) Zoomed in region of 
genome scan for CD23 MFI indicating location of Fcer2a, confidence intervals, and 
genomewide significance threshold. F) Estimated strain effects for CD23MFI (log base 10 
scale) at the Fcer2a locus.
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